May 19, 2022 (San Diego, CA) – Accomplished intellectual property attorney Jeffrey Morton has joined Procopio as a partner in its Del Mar Heights, California, office. Among his many clients are companies in the life sciences, from startups to fully mature enterprises. Jeff, whose science background includes a Ph.D. in Immunology, brings a holistic vision to his clients, crafting IP protection and commercialization strategies uniquely suited to each company’s technology, market niche, and growth ambitions.

“We’re thrilled to have a life sciences attorney of Jeff Morton’s caliber join us,” said Procopio Managing Partner John D. Alessio. “Our full-service legal practice in the life sciences and medical technology industry is growing rapidly, and he’s an excellent complement to ensure our clients receive the highest level of intellectual property legal service.”

Jeff provides strategic intellectual property advice, including patent prosecution, and related transactional support for emerging and mature companies in a wide variety of industries, with a particular focus on life sciences and medical technologies. He has extensive patent experience in technologies including genomics, immunology, and gene editing, and advises on complex freedom-to-operate life sciences issues. Jeff also maintains an active trademark practice and provides cross-border legal advice with Canadian clients, being admitted in both the U.S. and Canada. Jeff has been recognized by the World Intellectual Property Review as a U.S. Patent Leader and Trademark Leader and as an IAM Strategy 300 world-leading IP strategist.

“Joining Procopio is a natural next step in my career given the importance that I place on providing the best legal services to my clients,” said Jeff. “Procopio has established itself as a significant player in San Diego’s bustling life sciences community, and I’ve been very impressed at the caliber of the firm’s attorneys. As an IP attorney, I also welcome the opportunity to work side by side with Procopio’s impressive IP litigation and technology transaction attorneys, as my clients regularly find themselves in need of those services as well.”

Procopio’s Life Sciences attorneys bring decades of law firm and in-house counsel experience, from life-saving pharmaceuticals to breakthrough biotechnologies. The firm’s molecular biology experience includes gene therapy, next-generation sequencing and modern genomics, personalized cancer immunotherapy, TCRs, antibodies/peptibodies, antibody-drug conjugates (ADCs), protein therapeutics, cellular immunotherapy, and nucleic acids. Our chemistry technical expertise includes pharmaceuticals, industrial biotechnology, organic chemistry and polymer chemistry, in areas as diverse as peptide pharmaceuticals, adhesives, drug delivery technology, and medical devices. From emerging companies to established multinationals, Procopio provides a wide range of legal services to our life sciences clients, including IP counseling, IP litigation, licensing and technology transactions, corporate formation and venture capital, capital markets and securities, real estate transactions, and mergers & acquisitions and strategic joint ventures.

Procopio’s Intellectual Property team includes attorneys experienced in obtaining patents, trademarks and copyrights, securing trade secrets, and licensing and technology transactions. The firm’s patent prosecution attorneys serve clients in a wide range of industries, including life sciences, medical technologies, digital health, software, communications, optics, semiconductors, e-commerce, mechanical systems, computer networking and consumer goods. Procopio serves clients around the world, in particular Asia and Latin America, aided by affiliations with the global legal networks of Law Exchange International and Meritas.